Abstract
Although numerous clinical, laboratory, and pharmacological variables have been reported as significant risk factors for critical illness polyneuromyopathy (CIPM), there is still no consensus on the aetiology of this condition.
Objectives of the study were to assess the clinical and electrophysiological incidence and risk factors for CIPM.
A cohort of critically ill patients was observed prospectively for a one–month period and the association between neuromuscular involvement and various potential risk factors was evaluated. Sixty one critically ill patients completed the follow–up (30 women, 31 men, median age 59 years).
CIPM development was detected clinically in 17 patients (27.9 %) and electrophysiologically in 35 patients (57.4 %). CIPM was significantly associated with the presence and duration of systemic inflammatory response syndrome and the severity of multiple, respiratory, central nervous, and cardiovascular organ failures. The median duration of mechanical ventilation was significantly longer in patients with CIPM than in those without (16 vs 3 days, p < 0.001). Independent predictors of CIPM obtainable within the 1st week of critical illness were the admission sequential organ failure assessment score (odds ratio [OR], 1.15; 95% confidence interval [CI], 1.02–1.36), the 1st week total sequential organ failure assessment scores (OR, 1.14; 95 % CI, 1.06–1.46) and the 1st week duration of systemic inflammatory response syndrome (OR, 1.05; 95% CI, 1.01–1.15). They were able to correctly predict the development of CIPM at the end of the 1st week in about 80% of critically ill cases.
In conclusion, the presence and duration of systemic inflammatory response syndrome and the severity of multiple and several organ failures are associated with increased risk of the development of CIPM.
Similar content being viewed by others
References
Antonelli M, Moreno R, Vincent JL, Sprung CL, Mendoça A, Passariello M, Riccioni L, Osborn J and SOFA group (1999) Application of SOFA score to trauma patients. Intensive Care Med 25:389–394
Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL (1994) Prolonged paralysis due to non-depolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 17: 647–654
Bednarik J, Lukas Z, Vondracek P (2003) Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 29:1505–1514
Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ (1984) Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 47:1223–1231
Bolton CF, Ramsay DA, Rutledge F (1998) Acute quadriplegic myopathy (AQM), sepsis and the systemic inflammatory response syndrome (SIRS). Neurology 50:A242
Bolton CF, Breuer AC (1999) Critical illness polyneuropathy. Muscle Nerve 22:419–424
Bone RC, Sprung CL, Sibbald WJ (1992) Definitions for sepsis and organ failure. Crit Care Med 20:724–726
Campellone JV, Lacomis D, Kramer DJ, van Cott AC, Giuliani MJ (1998) Acute myopathy after liver transplantation. Neurology 50:46–53
Coakley JH, Nagendran K, Yarwood GD, Honavar M, Hinds CJ (1998) Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med 24:801–807
Deconinck N, Van PV, Beckers-Bleukx G, Van Den BP (1998) Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscul Disord 8:186–192
De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H, Bastuji-Garin S (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:2859–2867
De Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Meche FG (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29:2281–2286
Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, Garnacho-Montero MC, Moyano-Del-Estad MR (2001) Critical illness polyneuropathy: risk factors and clinical consequences.A cohort study in septic patients. Intensive Care Med 27:1288–1296
Geller TJ, Kaiboriboon K, Fenton GA, Hayat GR (2001) Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy? Neuromuscul Disord 11:579–582
Helliwell T, Coakley J, Wagenmakers AJ, Griffith DP, Campbell A, Green JV, McClelland B, Bone RC (1991) Necrotizing myopathy in critically ill patients. J Pathol 164:307–314
Hirano M, Ott BR, Raps EC, Minetti C, Lennihan L, Libbey NP, Bonilla E, Hays AP (1992) Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 42:2082–2087
Hund EF (1996) Neuromuscular complications in the ICU: the spectrum of critical illness-related conditions causing muscular weakness and weaning failure. J Neurol Sci 136:10–16
Hund EF (1999) Myopathy in critically ill patients. Crit Care Med 27:2544–2547
Hund EF (2001a) Critical illness polyneuropathy. Curr Opin Neurol 14:649–653
Hund EF (2001b) Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248:929–934
Hund EF, Fogel W, Krieger D, DeGeorgia M, Hacke W (1996) Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 24:1328–1333
Lacomis D, Zochodne DW, Bird SJ (2000) Critical illness myopathy. Muscle Nerve 23:1785–1788
Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, De Maria G, Antonini L, Rizzuto N, Candiani A (1996) Critical illness myopathy and neuropathy. Lancet 347:1579–1582
Lopez Messa JB, García A (1990) Acute polyneuropathy in critically ill patients. Intensive Care Med 16:159–162
MacFarlane IA, Rosenthal FD (1977) Severe myopathy after status asthmaticus. Lancet 2:615–620
Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/ failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 25:686–696
Op de Coul AAW, Lambregts PCLA, Koeman J, van Puyenbroek PJ, Ter Laak HJ, Gabreels-Festen AA (1985) Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 87:17–22
Op de Coul AA, Verheul GA, Leyten AC, Schellens RL, Teepen JL (1991) Critical illness polyneuromyopathy after artificial respiration. Clin Neurol Neurosurg 93:27–33
Rich MM, Bird SJ, Raps EC, Mc Cluskey LF, Teener JW (1997) Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20:665–673
Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD (1992) Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 327:524–528
Showalter CJ, Engel AG (1997) Acute quadriplegic myopathy: analysis of myosin isoforms and evidence of calpain-mediated proteolysis. Muscle Nerve 20:316–322
Tennila A, Salmi T, Pettila V, Roine RO, Varpula T, Takkunen O (2000) Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26:1360–1363
Trojaborg W, Weimer LH, Hays AP (2001) Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy–a reappraisal. Clin Neurophysiol 112:1568–1593
Van Marle W, Woods KL (1980) Acute hydrocortisone myopathy. BMJ 281:271–272
Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/ failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26:1793–1800
Wilmshurst PT, Treacher DF, Lantos PL, Wiles CM (1995) Critical illness poly-neuropathy following severe hyperpyrexia. QJM 88:351–355
Witt NJ, Zochodne DW, Bolton CF, Grand’Maison F, Wells G, Young GB, Sibbald WJ (1991) Peripheral nerve function in sepsis and multiple organ failure. Chest 99:176–184
Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA (1987) Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 110:819–841
Author information
Authors and Affiliations
Corresponding author
Additional information
The paper was presented as a lecture at the 54th Congress of the American Academy of Neurology 2002 in Denver and published as an abstract (Neurology 2002; Suppl. to 58: A159).
The work was supported by the Grant Project of the Internal Grant Agency of the Ministry of Health Care of the Czech Republic, No. NF-5980-3.
Rights and permissions
About this article
Cite this article
Bednarík, J., Vondracek, P., Dusek, L. et al. Risk factors for critical illness polyneuromyopathy. J Neurol 252, 343–351 (2005). https://doi.org/10.1007/s00415-005-0654-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0654-x